These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4441586)

  • 21. Growth hormone response to L-dopa in the thinned obese.
    Laurian L; Oberman Z; Hoerer E; Wiznitzer T; Harell A
    Isr J Med Sci; 1982 May; 18(5):625-9. PubMed ID: 7096047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-dopa stimulation at growth hormone release in normal subjects and in patients with Sheehan's syndrome.
    Himathongkam T; Tiyapan A; Rajatanavin R; Pitchayayothin N
    J Med Assoc Thai; 1981 Jan; 64(1):19-25. PubMed ID: 7217816
    [No Abstract]   [Full Text] [Related]  

  • 23. Growth hormone and IGF1 profile in short children with osteopetrosis.
    al Herbish AS; al Jarallah A; al Jurayyan NA; abo Bakr AM; al Rasheed SA; Mahdi AH
    Clin Invest Med; 1994 Feb; 17(1):26-30. PubMed ID: 8174311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Free fatty acids (FFA) blocking growth hormone secretion induced by L-Dopa].
    Casanueva F; Villanueva L; Peñalva A; Rodríguez R; Vila T; Cabezas-Cerrato J
    Rev Clin Esp; 1979 May; 153(3):217-20. PubMed ID: 482694
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the potentiating effect of pyridostigmine, arginine and propranolol on the GHRH-induced GH release in short children.
    Bellone J; Ghigo E; Procopio M; Arvat E; Valente F; Boffano GM; Maccario M; Dentelli P; Camanni F
    Panminerva Med; 1993 Mar; 35(1):1-4. PubMed ID: 8316397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Attempt at suppressing the THR-stimulated plasma growth hormone increase with the use of L-dopa in a cromegaly].
    Kasperlik-Zaluska A; Migdalska B; Wiśniewska-Woźniak T; Kaniewski M
    Endokrynol Pol; 1977; 28(1):31-5. PubMed ID: 401736
    [No Abstract]   [Full Text] [Related]  

  • 27. On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
    Hampshire J; Moraru E; Altszuler N
    Pharmacology; 1978; 17(3):138-48. PubMed ID: 704657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Growth hormone stimulation with L. Dopa].
    Elkaïm R; Halimi S; Guidicelli C; Agnius-Delord C; Hadjian A; Perret J; Micoud M
    Nouv Presse Med; 1972 Mar; 1(10):675-7. PubMed ID: 4553974
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Enhancement of levodopa-induced growth-hormone stimulation by propranolol.
    Camanni F; Massara F
    Lancet; 1974 May; 1(7863):942. PubMed ID: 4133478
    [No Abstract]   [Full Text] [Related]  

  • 30. [Circadian variations in the plasma GH response to stimulation with L-dopa in normal women].
    Bellastella A; D'Alessandro B; Esposito V; De Luca R; Officioso A
    Boll Soc Ital Biol Sper; 1977 Dec; 53(23):2329-32. PubMed ID: 610753
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulatory effect of levodopa and propranolol upon plasma growth hormone release in children and adolescents.
    Reddy CM
    Indian J Pediatr; 1980; 47(384):85-8. PubMed ID: 7216342
    [No Abstract]   [Full Text] [Related]  

  • 33. [Amantadine potentiation of G.H. relase evoked by L-dopa and its inhibition by nonesterified fatty acids].
    Cabezas-Cerrato J; Casanueva Freijo F; Villanueva Aranguren L; Avila C; Fernández-Cruz A
    Rev Clin Esp; 1977 May; 145(3):165-8. PubMed ID: 866739
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of growth hormone secretion during sleep and after L-dopa.
    Kulesza B; Blaim A; Palińska-Cudnoch M
    Mater Med Pol; 1977; 9(1):34-6. PubMed ID: 875451
    [No Abstract]   [Full Text] [Related]  

  • 35. Impaired responses of growth hormone and blood eosinophils to L-dopa in atopy [proceedings].
    Szczeklik A; Serwońska M; Pietoń R; Podolec Z; Sieradzki J
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):703. PubMed ID: 749825
    [No Abstract]   [Full Text] [Related]  

  • 36. [Differential diagnosis of growth disorders based on the determination of growth hormone secretion following administration of L-dopa].
    Gembicki M; Kosowicz J; Sobieszczyk S
    Pol Arch Med Wewn; 1975 Aug; 54(2):147-52. PubMed ID: 1161535
    [No Abstract]   [Full Text] [Related]  

  • 37. Growth hormone refractory interval to levodopa stimulation.
    Parker KM; Eddy RL
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1188-91. PubMed ID: 932184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Circadian variations in the plasma GH response to L-dopa stimulation in female obesity].
    D'Alessandro B; Bellastella A; Cafaro MR; De Luca R; Esposito V
    Boll Soc Ital Biol Sper; 1977 Dec; 53(23):2333-6. PubMed ID: 610754
    [No Abstract]   [Full Text] [Related]  

  • 39. [Stimulation of growth hormone (HGH) with L-dopa].
    Gosselin L; Bolduc R; Verreault R
    Union Med Can; 1974 Sep; 103(9):1552-6. PubMed ID: 4439528
    [No Abstract]   [Full Text] [Related]  

  • 40. [Autonomic nervous system and HCG secretion. II. Effect of adrenergic blockaders on the excretion of HCG following intravenous loading of tolbutamide].
    Carducci Artenisio A; Sprovieri M; Alibrando S; Albanese MC; Allegra V; Ragonese F; Corsi V
    Folia Endocrinol; 1973 Jun; 26(3):206-16. PubMed ID: 4740901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.